Prevention of Groin Injuries in Rink Hockey

April 2, 2024 updated by: Hugo Olmedillas Fernandez, University of Oviedo

Prevention of Groin Injuries in Rink Hockey: A One Season Natural Experiment

Rink hockey teams from senior category (adults) will be recruited to implement a groin injury prevention program consisting on the Copenhagen Adduction Exercise (CAE) throughout the regular season, 0 times, once or twice per week (september 2023-march 2024)

Weekly team exposure to training sessions and games will be collected as well as cases of groin problems in the entire population

When the season ends, the number of groin problems will be compared between teams that used the prevention program once a week against twice a week or no sessions a week.

Study Overview

Status

Completed

Detailed Description

Rink hockey teams will be offered a prevention program consisting on the CAE to be performed during the season.

Teams will decide to implement the protocol once, twice or 0 times per week, depending on their schedule. No formal control group will be set, comparison of injuries will be performed between teams that used +80% of the total possible sessions and -80% (28 weeks equals a potential 42 CAE sessions throughout the season).

On a weekly basis, coaches will be contacted to report number of training sessions, games, and training sessions where they implemented CAE.

Bi-weekly, players will report any episode of groin problems (both leading to time-loss and those only affecting performance while not limiting participation).

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Asturias
      • Oviedo, Asturias, Spain, 33006

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • #1 Be part of a rink hockey team competing in senior league (either local (third division/lower) or national (first and second division))

    • 2 Accept participating in the study (signing the informed consent)

Exclusion Criteria:

  • #1 not playing rink hockey in the previous season

    • 2 serious illness, injury or surgery in the previous 6 months that prevented rink hockey participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Copenhagen Adduction Exercise Group
there is no control group, all teams can implement the intervention protocol that better fits their normal schedule, the intervention can consist of 1 or 2 Copenhagen Adduction Exercise sessions per week
The CAE is performed by side-lying on the floor with the dominant lower limb supported in the air by a teammate, the hip is adducted until the body forms a straight line from the ankles to the shoulders (concentric phase), then the player is instructed to lower the body slowly (eccentric phase) until reaching the floor to start the next repetition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bi-Weekly prevalence of groin problems
Time Frame: Every 14 days throughout the entire study (which lasts 7 months)
number of groin pain complaints in a 14-day frame, groin pain is described as pain in the groin region which emerges from performing exercise and may be indicative of an injury to the adductor muscles, abdominals, hip flexors, or pubic joint
Every 14 days throughout the entire study (which lasts 7 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the intervention
Time Frame: Every 7 days throughout the entire study (which lasts 7 months)
Since the intervention is implemented on a weekly basis, the number of sessions performed by the participating teams will be collected to calculate the total compliance with the intervention. From a total of 56 possible sessions a team may complete 47 which equals 83% compliance
Every 7 days throughout the entire study (which lasts 7 months)
hockey exposure
Time Frame: Every 7 days throughout the entire study (which lasts 7 months)
number of training sessions and games per week this metric is collected to calculate exposure hours, so that groin problems can be compared as nº of injuries / 1000 hours of exposure, as the International Olympic Committee recommends
Every 7 days throughout the entire study (which lasts 7 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

March 30, 2024

Study Completion (Actual)

April 1, 2024

Study Registration Dates

First Submitted

August 5, 2023

First Submitted That Met QC Criteria

August 11, 2023

First Posted (Actual)

August 16, 2023

Study Record Updates

Last Update Posted (Actual)

April 4, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UO2023/1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Groin Injury

Clinical Trials on Copenhagen Adduction Exercise

3
Subscribe